Chinese biotech startup LianBio, set up by US hedge fund Perceptive Advisors, is planning to launch an initial public offering on the Nasdaq Global Market, per its filing with the US Securities and Exchange Commission.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
